Non-Insulin Therapies for Diabetes Market Data Survey Report 2013-2025

Table of Contents
1 Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 GSK
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Eli Lilly
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 Sumitomo Dainippon Pharma
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Intarcia Therapeutics
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 Servier
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 Jiangsu Hansoh Pharmaceutical
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Novo Nordisk
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7.4 Recent Development
3.8 Emisphere
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8.4 Recent Development
3.9 Uni-Bio Science Group
3.9.1 Company Information
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9.4 Recent Development
3.10 Takeda
3.10.1 Company Information
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10.4 Recent Development
3.11 3SBio
3.11.1 Company Information
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11.4 Recent Development
3.12 Merck
3.12.1 Company Information
3.12.2 Product & Services
3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.12.4 Recent Development
3.13 Dong-A Pharmaceutical
3.13.1 Company Information
3.13.2 Product & Services
3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.13.4 Recent Development
3.14 Luye Pharma Group
3.14.1 Company Information
3.14.2 Product & Services
3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.14.4 Recent Development
3.15 Eurofarma
3.15.1 Company Information
3.15.2 Product & Services
3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.15.4 Recent Development
3.16 Geropharm
3.16.1 Company Information
3.16.2 Product & Services
3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.16.4 Recent Development
3.17 Alkem Labs
3.17.1 Company Information
3.17.2 Product & Services
3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.17.4 Recent Development
3.18 SatRx
3.18.1 Company Information
3.18.2 Product & Services
3.18.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.18.4 Recent Development
3.19 Pfizer
3.19.1 Company Information
3.19.2 Product & Services
3.19.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.20 Jiangsu Hengrui Medicine
3.20.1 Company Information
3.20.2 Product & Services
3.20.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Hospital Pharmacy
4.1.1 Overview
4.1.2 Hospital Pharmacy Market Size and Forecast
4.2 Retail Pharmacies
4.2.1 Overview
4.2.2 Retail Pharmacies Market Size and Forecast
4.3 Online Pharmacy
4.3.1 Overview
4.3.2 Online Pharmacy Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast
5 Market by Type
5.By Alpha-glucosidase Inhibitors
5.1 Alpha-glucosidase Inhibitors
5.1.1 Overview
5.1.2 Alpha-glucosidase Inhibitors Market Size and Forecast
5.2 Amylin Agonists
5.2.1 Overview
5.2.2 Amylin Agonists Market Size and Forecast
5.3 Biguanides
5.3.1 Overview
5.3.2 Biguanides Market Size and Forecast
5.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
5.4.1 Overview
5.4.2 Dipeptidyl Peptidase-4 (DPP4) Inhibitors Market Size and Forecast
5.5 Glinides / Meglitinides
5.5.1 Overview
5.5.2 Glinides / Meglitinides Market Size and Forecast
5.6 GLP-1 Analogs / GLP-1 Agonists
5.6.1 Overview
5.6.2 GLP-1 Analogs / GLP-1 Agonists Market Size and Forecast
5.7 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
5.7.1 Overview
5.7.2 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Market Size and Forecast
5.8 Sulfonylureas
5.8.1 Overview
5.8.2 Sulfonylureas Market Size and Forecast
5.9 Thiazolidinediones
5.9.1 Overview
5.9.2 Thiazolidinediones Market Size and Forecast
5.10 Others
5.10.1 Overview
5.10.2 Others Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion